+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalation & Nasal Sprays Generic Drugs Market by Route Of Administration (Inhalation, Nasal), Patient Age Group (Adult, Geriatric, Pediatric), Formulation, Distribution Channel, End User, Application - Global Forecast 2025-2030- Product Image
Inhalation & Nasal Sprays Generic Drugs Market by Route Of Administration (Inhalation, Nasal), Patient Age Group (Adult, Geriatric, Pediatric), Formulation, Distribution Channel, End User, Application - Global Forecast 2025-2030- Product Image
Sale

Inhalation & Nasal Sprays Generic Drugs Market by Route Of Administration (Inhalation, Nasal), Patient Age Group (Adult, Geriatric, Pediatric), Formulation, Distribution Channel, End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014109
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The inhalation and nasal sprays generic drugs market is undergoing notable transformation, with increasing demand for cost-effective respiratory treatments driving new opportunities and intensifying competition. Decision-makers face a landscape shaped by evolving clinical needs, policy changes, and rapid advances in delivery technologies.

Market Snapshot: Inhalation & Nasal Sprays Generic Drugs Market

The inhalation and nasal sprays generic drugs market grew from USD 8.78 billion in 2024 to USD 9.56 billion in 2025. It is projected to expand at a compound annual growth rate (CAGR) of 8.64%, reaching USD 14.44 billion by 2030.

Scope & Segmentation of the Market

This comprehensive report examines the breadth of the inhalation and nasal sprays generic drugs market by exploring multiple dimensions that matter most to strategic decision-makers:

  • Route of Administration: Includes inhalation formulations such as dry powder inhalers, metered dose inhalers, nebulizers, and soft mist inhalers, as well as nasal spray products.
  • Patient Age Group: Spans adults, geriatric patients, and pediatrics, each presenting distinct therapeutic and device needs.
  • Formulation Types: Covers dry powder, solutions, and suspensions tailored to solubility and stability requirements.
  • Distribution Channels: Focuses on hospital pharmacies, online pharmacies, and retail pharmacies, each with unique access and purchasing models.
  • End Users: Encompasses ambulatory care, home care, and hospital-based usage environments.
  • Therapeutic Applications: Highlights bronchodilators, combination therapies, and corticosteroids for varied respiratory indications.
  • Geographic Coverage: Analyzes regional markets across the Americas (including United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (with key countries like UK, Germany, France, Saudi Arabia, South Africa, and more), and Asia-Pacific (covering China, India, Japan, Australia, Southeast Asian countries, and others).
  • Key Company Profiles: Evaluates leading organizations such as Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Viatris Inc, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Lupin Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals, and Glenmark Pharmaceuticals Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • Patent expirations and regulatory advancements are boosting the entry of new generics, intensifying competition and requiring differentiated value propositions.
  • Personalized medicine and innovations in formulation platforms are driving manufacturers to invest in adaptable solutions that address diverse patient populations.
  • Adoption of digital monitoring technologies in inhalers is enhancing treatment adherence and generating actionable clinical data for providers and payers.
  • Sustainability imperatives—including advancements in propellant systems and device recyclability—are becoming critical differentiators for product design and regulatory compliance.
  • Emerging markets, specifically in Asia-Pacific, present high growth potential due to government incentives, expanded manufacturing capacity, and innovative distribution models such as e-commerce.
  • Strategic alliances, licensing, and capacity expansions among key players are fostering integrated solutions and supporting more complex generic submissions.

Impact of United States Tariffs in 2025

The imposition of tariffs on pharmaceutical ingredients and finished products in 2025 has prompted manufacturers to adjust procurement strategies and accelerate local API production. Some have adopted regionalization or entered strategic partnerships to mitigate increased costs, resulting in a heightened emphasis on supply chain agility and operational resilience throughout the downstream value chain.

Methodology & Data Sources

The research methodology integrates primary interviews with regulatory bodies, industry stakeholders, and clinical experts. Secondary data was synthesized from scientific literature, clinical trial registries, patent databases, and regulatory publications. Triangulation was performed to ensure consistency, with all findings subject to peer review for enhanced reliability.

Why This Report Matters

  • Enables senior leaders to navigate regional dynamics, regulatory developments, and segment-specific opportunities for more effective investment planning.
  • Delivers actionable insights into technology trends, market access strategies, and partnership frameworks to strengthen competitive positioning.

Conclusion

The inhalation and nasal sprays generic drugs market is set for continued transformation, driven by advances in technology, regulation, and evolving clinical needs. Stakeholders equipped with this analysis are positioned to make informed decisions, strengthen their portfolios, and respond proactively to market shifts.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Acceleration of complex device co-development partnerships for generic nasal spray delivery systems
5.2. Rising adoption of bioequivalence emphasis in regulatory guidelines for inhalation generics
5.3. Growth of low-cost Indian manufacturers disrupting the global generic nasal spray market dynamics
5.4. Integration of digital adherence sensors into generic inhaler devices to enhance patient compliance
5.5. Pipeline expansion of generic inhalation corticosteroids amid patent expirations of major brands
5.6. Increased investments in advanced spray drying technology for high potency generic pulmonary drugs
5.7. Emergence of nasal powder formulations to bypass cold chain requirements in generic drug supply
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhalation & Nasal Sprays Generic Drugs Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Nebulizer
8.2.4. Soft Mist Inhaler
8.3. Nasal
9. Inhalation & Nasal Sprays Generic Drugs Market, by Patient Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Inhalation & Nasal Sprays Generic Drugs Market, by Formulation
10.1. Introduction
10.2. Dry Powder
10.3. Solution
10.4. Suspension
11. Inhalation & Nasal Sprays Generic Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Inhalation & Nasal Sprays Generic Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.3. Home Care
12.4. Hospital
13. Inhalation & Nasal Sprays Generic Drugs Market, by Application
13.1. Introduction
13.2. Bronchodilator
13.3. Combination
13.4. Corticosteroid
14. Americas Inhalation & Nasal Sprays Generic Drugs Market
14.1. Introduction
14.2. United States
14.3. Mexico
14.4. Brazil
14.5. Canada
14.6. Argentina
15. Europe, Middle East & Africa Inhalation & Nasal Sprays Generic Drugs Market
15.1. Introduction
15.2. United Arab Emirates
15.3. Israel
15.4. Netherlands
15.5. Russia
15.6. Germany
15.7. Poland
15.8. Sweden
15.9. Italy
15.10. Saudi Arabia
15.11. Finland
15.12. Turkey
15.13. Qatar
15.14. France
15.15. Nigeria
15.16. Egypt
15.17. South Africa
15.18. Spain
15.19. Switzerland
15.20. United Kingdom
15.21. Denmark
15.22. Norway
16. Asia-Pacific Inhalation & Nasal Sprays Generic Drugs Market
16.1. Introduction
16.2. Taiwan
16.3. India
16.4. Australia
16.5. Vietnam
16.6. Philippines
16.7. Malaysia
16.8. Indonesia
16.9. Japan
16.10. China
16.11. South Korea
16.12. Thailand
16.13. Singapore
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Teva Pharmaceutical Industries Ltd
17.3.2. Sandoz International GmbH
17.3.3. Viatris Inc
17.3.4. Sun Pharmaceutical Industries Ltd
17.3.5. Cipla Ltd
17.3.6. Dr. Reddy’s Laboratories Ltd
17.3.7. Lupin Limited
17.3.8. Hikma Pharmaceuticals PLC
17.3.9. Amneal Pharmaceuticals, Inc
17.3.10. Glenmark Pharmaceuticals Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RESEARCHAI
FIGURE 28. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DRY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY BRONCHODILATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COMBINATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 186. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 187. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 200. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 201. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 242. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 243. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 244. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 245. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 246. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 247. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 272. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 273. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. ITALY INHALATION

Samples

Loading
LOADING...

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Viatris Inc
  • Sun Pharmaceutical Industries Ltd
  • Cipla Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Lupin Limited
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals, Inc
  • Glenmark Pharmaceuticals Ltd

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.44 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report - Product Image

Inhalation and Nasal Spray Generic Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Inhalation and Nasal Spray Generic Drugs Market Report 2025 - Product Image

Inhalation and Nasal Spray Generic Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030 - Product Image

Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Generic Central Nervous System Drugs Market Report 2025 - Product Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.